Radiation-Induced Enhancement of Antitumor T-cell Immunity by VEGF-Targeted 4-1BB Costimulation. 2017

Brett Schrand, and Bhavna Verma, and Agata Levay, and Shradha Patel, and Iris Castro, and Ana Paula Benaduce, and Randall Brenneman, and Oliver Umland, and Hideo Yagita, and Eli Gilboa, and Adrian Ishkanian
Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, Florida.

Radiotherapy can elicit systemic immune control of local tumors and distant nonirradiated tumor lesions, known as the abscopal effect. Although this effect is enhanced using checkpoint blockade or costimulatory antibodies, objective responses remain suboptimal. As radiotherapy can induce secretion of VEGF and other stress products in the tumor microenvironment, we hypothesized that targeting immunomodulatory drugs to such products will not only reduce toxicity but also broaden the scope of tumor-targeted immunotherapy. Using an oligonucleotide aptamer platform, we show that radiation-induced VEGF-targeted 4-1BB costimulation potentiated both local tumor control and abscopal responses with equal or greater efficiency than 4-1BB, CTLA-4, or PD1 antibodies alone. Although 4-1BB and CTLA-4 antibodies elicited organ-wide inflammatory responses and tissue damage, VEGF-targeted 4-1BB costimulation produced no observable toxicity. These findings suggest that radiation-induced tumor-targeted immunotherapy can improve the therapeutic index and extend the reach of immunomodulatory agents. Cancer Res; 77(6); 1310-21. ©2017 AACR.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D005720 Gamma Rays Penetrating, high-energy electromagnetic radiation emitted from atomic nuclei during NUCLEAR DECAY. The range of wavelengths of emitted radiation is between 0.1 - 100 pm which overlaps the shorter, more energetic hard X-RAYS wavelengths. The distinction between gamma rays and X-rays is based on their radiation source. Gamma Wave,Gamma Radiation,Nuclear X-Rays,Radiation, Gamma,X-Rays, Nuclear,Gamma Radiations,Gamma Ray,Gamma Waves,Nuclear X Rays,Nuclear X-Ray,Ray, Gamma,Wave, Gamma,Waves, Gamma,X Rays, Nuclear,X-Ray, Nuclear
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D042461 Vascular Endothelial Growth Factor A The original member of the family of endothelial cell growth factors referred to as VASCULAR ENDOTHELIAL GROWTH FACTORS. Vascular endothelial growth factor-A was originally isolated from tumor cells and referred to as "tumor angiogenesis factor" and "vascular permeability factor". Although expressed at high levels in certain tumor-derived cells it is produced by a wide variety of cell types. In addition to stimulating vascular growth and vascular permeability it may play a role in stimulating VASODILATION via NITRIC OXIDE-dependent pathways. Alternative splicing of the mRNA for vascular endothelial growth factor A results in several isoforms of the protein being produced. Vascular Endothelial Growth Factor,Vascular Endothelial Growth Factor-A,GD-VEGF,Glioma-Derived Vascular Endothelial Cell Growth Factor,VEGF,VEGF-A,Vascular Permeability Factor,Vasculotropin,Glioma Derived Vascular Endothelial Cell Growth Factor,Permeability Factor, Vascular
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Brett Schrand, and Bhavna Verma, and Agata Levay, and Shradha Patel, and Iris Castro, and Ana Paula Benaduce, and Randall Brenneman, and Oliver Umland, and Hideo Yagita, and Eli Gilboa, and Adrian Ishkanian
January 2019, Frontiers in immunology,
Brett Schrand, and Bhavna Verma, and Agata Levay, and Shradha Patel, and Iris Castro, and Ana Paula Benaduce, and Randall Brenneman, and Oliver Umland, and Hideo Yagita, and Eli Gilboa, and Adrian Ishkanian
August 2007, Cancer research,
Brett Schrand, and Bhavna Verma, and Agata Levay, and Shradha Patel, and Iris Castro, and Ana Paula Benaduce, and Randall Brenneman, and Oliver Umland, and Hideo Yagita, and Eli Gilboa, and Adrian Ishkanian
March 2024, bioRxiv : the preprint server for biology,
Brett Schrand, and Bhavna Verma, and Agata Levay, and Shradha Patel, and Iris Castro, and Ana Paula Benaduce, and Randall Brenneman, and Oliver Umland, and Hideo Yagita, and Eli Gilboa, and Adrian Ishkanian
January 1997, Journal of immunology (Baltimore, Md. : 1950),
Brett Schrand, and Bhavna Verma, and Agata Levay, and Shradha Patel, and Iris Castro, and Ana Paula Benaduce, and Randall Brenneman, and Oliver Umland, and Hideo Yagita, and Eli Gilboa, and Adrian Ishkanian
June 2015, Nature medicine,
Brett Schrand, and Bhavna Verma, and Agata Levay, and Shradha Patel, and Iris Castro, and Ana Paula Benaduce, and Randall Brenneman, and Oliver Umland, and Hideo Yagita, and Eli Gilboa, and Adrian Ishkanian
February 1999, Cellular immunology,
Brett Schrand, and Bhavna Verma, and Agata Levay, and Shradha Patel, and Iris Castro, and Ana Paula Benaduce, and Randall Brenneman, and Oliver Umland, and Hideo Yagita, and Eli Gilboa, and Adrian Ishkanian
January 2003, Cytokine & growth factor reviews,
Brett Schrand, and Bhavna Verma, and Agata Levay, and Shradha Patel, and Iris Castro, and Ana Paula Benaduce, and Randall Brenneman, and Oliver Umland, and Hideo Yagita, and Eli Gilboa, and Adrian Ishkanian
February 2003, European journal of immunology,
Brett Schrand, and Bhavna Verma, and Agata Levay, and Shradha Patel, and Iris Castro, and Ana Paula Benaduce, and Randall Brenneman, and Oliver Umland, and Hideo Yagita, and Eli Gilboa, and Adrian Ishkanian
January 2018, JCI insight,
Brett Schrand, and Bhavna Verma, and Agata Levay, and Shradha Patel, and Iris Castro, and Ana Paula Benaduce, and Randall Brenneman, and Oliver Umland, and Hideo Yagita, and Eli Gilboa, and Adrian Ishkanian
June 2019, Cancer immunology research,
Copied contents to your clipboard!